Pancreatic ductal adenocarcinoma (PDAC)

Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies

Nel AE, Luo L, Liao YP, Wang X. Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant[...]

By afschroeder • November 23, 2025

Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review

Dayyani F, Macarulla T, Johnson A, Wainberg ZA. Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review. Cancer Treat Rev.[...]

By sjmartinez • February 8, 2023